Citadel Advisors’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.3M Sell
1,175,097
-195,526
-14% -$1.05M ﹤0.01% 1718
2025
Q1
$7.32M Buy
1,370,623
+438,644
+47% +$2.34M ﹤0.01% 1476
2024
Q4
$8.33M Buy
931,979
+141,225
+18% +$1.26M ﹤0.01% 1432
2024
Q3
$8.71M Sell
790,754
-623,587
-44% -$6.87M ﹤0.01% 1365
2024
Q2
$12.9M Buy
1,414,341
+536,190
+61% +$4.88M ﹤0.01% 1084
2024
Q1
$12.4M Buy
878,151
+734,493
+511% +$10.3M ﹤0.01% 1169
2023
Q4
$1.1M Buy
143,658
+122,209
+570% +$939K ﹤0.01% 2934
2023
Q3
$160K Buy
21,449
+21,014
+4,831% +$157K ﹤0.01% 4641
2023
Q2
$3.62K Sell
435
-18,349
-98% -$153K ﹤0.01% 5492
2023
Q1
$250K Sell
18,784
-120,562
-87% -$1.6M ﹤0.01% 4455
2022
Q4
$2.07M Buy
139,346
+16,870
+14% +$251K ﹤0.01% 2545
2022
Q3
$1.11M Sell
122,476
-97,486
-44% -$882K ﹤0.01% 3319
2022
Q2
$659K Sell
219,962
-23,827
-10% -$71.4K ﹤0.01% 3861
2022
Q1
$1.64M Buy
243,789
+21,392
+10% +$144K ﹤0.01% 3230
2021
Q4
$1.2M Sell
222,397
-88,192
-28% -$475K ﹤0.01% 3606
2021
Q3
$2.75M Sell
310,589
-15,752
-5% -$139K ﹤0.01% 2653
2021
Q2
$4.13M Buy
326,341
+319,219
+4,482% +$4.04M ﹤0.01% 2374
2021
Q1
$124K Sell
7,122
-3,725
-34% -$64.9K ﹤0.01% 5721
2020
Q4
$139K Buy
+10,847
New +$139K ﹤0.01% 4602
2020
Q3
Sell
-2,860
Closed -$111K 4655
2020
Q2
$111K Buy
+2,860
New +$111K ﹤0.01% 4220
2020
Q1
Sell
-1,698
Closed -$60K 4824
2019
Q4
$60K Buy
+1,698
New +$60K ﹤0.01% 4362
2018
Q3
Sell
-664
Closed -$38K 4266
2018
Q2
$38K Buy
+664
New +$38K ﹤0.01% 3943
2017
Q2
Sell
-466
Closed -$45K 3636
2017
Q1
$45K Buy
+466
New +$45K ﹤0.01% 3415